ArticleMicrobial cell factories2025
Development of a markerless tool for targeted chromosome modification in the thermophilic and methylotrophic bacterium Bacillus methanolicus.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Harnessing the thermotolerant methylotroph Bacillus methanolicus for methanol-based synthetic L-proline production.Microbial cell factories · 2026Article
- CRISPR-Cas9-driven genome editing inFrontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBacillus methanolicus is a promising candidate to become an industrial workhorse for methanol-based bioproduction due to its methylotrophy. However, genetic toolbox for this biotechnologically relevant thermophilic bacterium is still limited.
resultsWe here present the establishment of a counterselection system conducive to genome modifications in Bacillus methanolicus MGA3. We first identified four candidate genes or operons feasible to become counterselection markers: lacZ from Bacillus coagulans, sacB from Bacillus subtilis, codBA from Escherichia coli, and oroP from Lactococcus lactis, based on their absence from the genome of B. methanolicus. We tested substrates of the encoded enzymes to confirm their lack of toxicity to wild type B. methanolicus. Experimental results confirmed that none of the tested substrates affected the growth of B. methanolicus wild type at physiologically relevant concentrations. Subsequently, the selected genes were individually cloned into a low-copy plasmid pTH1mp and used to transform B. methanolicus. We evaluated the conversion of these non-toxic substrates to toxic products upon heterologous expression of the respective marker genes in B. methanolicus. The recombinant strains were demonstrated to possess the desired counterselection activity through lack of growth in the presence of their relevant substrate. A novel transconjugation method for high-efficiency plasmid-delivery of B. methanolicus was developed and used for the establishment of genome modification via non-replicating suicide vector designed for homologous recombination. Deletion of the chromosomal upp gene, crucial for uracil metabolism, was achieved using this method.
conclusionsIn this study, we confirmed the utility of the established oroP-based counterselection system for the genome modifications through deletion of upp gene in B. methanolicus. The deletion strain exhibited reduced sensitivity to 5-fluorouracil, the toxic substrate of the upp encoded enzyme, demonstrating the practical application of the counterselection markers in genome engineering of B. methanolicus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.